American Journal of Kidney Diseases
Volume 51, Issue 4, Supplement 2 , Pages S21-S29 , April 2008

Diabetes Mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004

  • Adam T. Whaley-Connell, DO, MSPH

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S Truman VA Medical Center, Columbia, MO
    • Corresponding Author InformationAddress correspondence to Adam T. Whaley-Connell, DO, MSPH, Assistant Professor of Medicine, University of Missouri-Columbia School of Medicine, Department of Internal Medicine, Division of Nephrology, MA436, DC043.0, One Hospital Dr, Columbia, MO 65212.
    • ,
  • James R. Sowers, MD

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S Truman VA Medical Center, Columbia, MO
    • ,
  • Samy I. McFarlane, MD, MPH

      Affiliations

    • SUNY Downstate, Brooklyn, NY
    • ,
  • Keith C. Norris, MD

      Affiliations

    • Charles R. Drew University of Medicine and Science, Los Angeles, CA
    • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
    • ,
  • Shu-Cheng Chen, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Suying Li, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Yang Qiu, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Changchun Wang, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Lesley A. Stevens, MD

      Affiliations

    • Tufts-New England Medical Center, Boston, MA
    • ,
  • Joseph A. Vassalotti, MD

      Affiliations

    • National Kidney Foundation, New York, NY
    • Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY.
    • ,
  • Allan J. Collins, MD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Kidney Early Evaluation Program Investigators

Received 7 November 2007 ,Accepted 11 December 2007.

References 

  1. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;50(suppl 2):S1–S179
  2. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  3. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–3741
  4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  5. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  6. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495
  7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  8. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  9. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42:22–35
  10. Brown WW, Collins A, Chen SC, et al. Identification of persons at high risk for kidney disease via targeted screening: The NKF Kidney Early Evaluation Program. Kidney Int Suppl. 2003;83:S50–S55
  11. Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW. The Kidney Early Evaluation Program (KEEP): Program design and demographic characteristics of the population. Am J Kidney Dis. 2008;51(suppl 2):S3–S12
  12. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  13. Stevens LA, Stoycheff N. Standardization of serum creatinine and estimated glomerular filtration rate in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008;51(suppl 2):S77–S82
  14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–2572
  15. McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007;167:1122–1129
  16. McGill JB, Brown WW, Chen SC, Collins AJ, Gannon MR Kidney Early Evaluation Program (KEEP). Findings from a community screening program. Diabetes Educ. 2004;30:196–206
  17. National Kidney Foundation. KEEP Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2003;42(suppl 4):S3–S60
  18. National Kidney Foundation. KEEP Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2005;45(suppl 2):S1–S136
  19. National Kidney Foundation. KEEP Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2005;46(suppl 3):S1–S158
  20. Kidney Early Evaluation Program. Annual Data Report. Am J Kidney Dis. 2007;49(suppl 3):S1–S160
  21. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention, Department of Health and Human Services; 2003;
  22. US Department of Health and Human Services. Healthy People 2010, Diabetes Progress Review 2002. (ed 2). Washington, DC: US Government Printing Office; 2002;
  23. MacIsaac RJ, Jerums G, Cooper ME. New insights into the significance of microalbuminuria. Curr Opin Nephrol Hypertens. 2004;13:83–91
  24. Lane JT. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: A temporal perspective. Am J Physiol Renal Physiol. 2004;286:F442–F450
  25. Sowers JR, Haffner S. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension. 2002;40:781–788
  26. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab. 2001;86:713–718
  27. De Cosmo S, Minenna A, Ludovico O, et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: Evidence of a sex-specific association. Diabetes Care. 2005;28:910–915

 A list of the members of the Kidney Early Evaluation Program Investigators appears at the end of this article.

PII: S0272-6386(07)01665-4

doi: 10.1053/j.ajkd.2007.12.013

American Journal of Kidney Diseases
Volume 51, Issue 4, Supplement 2 , Pages S21-S29 , April 2008

Article Tools

* Image Usage & Resolution